1-3 of 3
John R Strahler, PhD
Close
Sort by
Journal Articles

Proteomic Signature Predicting Achievement of Very Good Partial Response In Patients with Multiple Myeloma Based On Complementary Label-Free and iTRAQ Quantitative Proteome Analysis

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1902.
https://doi.org/10.1182/blood.V116.21.1902.1902
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Paul G Richardson, MD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 618.
https://doi.org/10.1182/blood.V116.21.618.618
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma Plasma Cells and Normal Plasma Cells Reveals Differential Expression of Clu1 and Basp1 Proteins

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, Stephanie J Kraftson, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Alexey Nesvizhskii, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4034.
https://doi.org/10.1182/blood.V116.21.4034.4034
Published: 2010